Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load

Inclusion Criteria: * Man aged 18-69 years; * Man with documented infection with sub-type B HIV-1; * On cART since more than 36 months before pre- screening and at a stable regimen for at least 2 months before pre-screening and until inclusion; * HIV plasma viral load persistently \< the threshold (of the local test used) and undetectable during the 12 months prior to pre-screening and until inclusion; * CD4+ T-cells count nadir ≥ 200 cells per mm3 documented in the medical file; Transient CD4+ T-cells count \< 200 cells per mm3 is allowed for a short period if the value is associated with a single isolated acute infection * CD4+ T-cells count ≥ 500 cells per mm3 for at least 12 months before pre-screening and until inclusion; * EBV viral load \< 1000 cp.mL-1, CMV viral load \< 10000 cp mL-1; * Able and willing to comply with study visits and procedures as per protocol; * Able to understand, sign and date the written voluntary informed consent form at the pre screening visit prior to any protocol-specific procedures. * Free, informed and written consent signed by the person and the investigator (at the latest on the day of pre-screening and before any investigation carried out as part of the trial) (law of 7 May 2004. article 6) Exclusion Criteria: * Man who want to father a child or refuse contraception (condoms) while receiving treatment and for 3 months following completion of treatment; Man with a female partner of childbearing potential who refuses to use …